← Glossary

Aging and mechanisms

The words that describe what changes with age, from muscle to cell. Each entry locates the mechanism, what it means in coaching, and the level of evidence behind it.

Sarcopenia#

Age-related loss of both muscle mass and muscle strength. It affects about one adult in six after age 60 and begins around age 30. It does not show on the scale: weight can stay stable while lean mass falls and fat mass rises. Screening relies on strength, walking speed and chair-stand time.

Dynapenia#

Age-related loss of muscle strength, which often precedes loss of mass. Strength can fall while muscle mass stays stable, which explains why a person of normal weight can already be at risk. That is why screening starts with the dynamometer and the chair stand, not the scale.

FrailtyFrailty syndrome#

Geriatric syndrome associated with a higher risk of falls, hospitalization and death. The Fried phenotype identifies it on five criteria: unintentional weight loss, exhaustion, muscle weakness, slow walking speed and reduced physical activity. Three criteria are enough to speak of frailty, and the syndrome is reversible in some cases.

Hormesis#

Response of the body to a moderate challenge followed by a repair phase, which leaves resistance capacity higher than before. An appropriate dose produces a benefit, an excessive dose produces damage. It is a framework for placing a practice in the useful zone, not a magic property of stress.

Low-grade inflammationInflammaging · Chronic low-grade inflammation#

Persistent inflammatory state without infection, associated with higher morbidity and mortality. It is listed among the hallmarks of aging, which does not make a high value a diagnosis. An isolated C-reactive protein does not distinguish a chronic state from a transient episode linked to an infection, an injury or recent exertion.

Biological age#

Estimate of the state of the body independent of date of birth. The term covers methods that have nothing in common: calculations from blood tests, methylation clocks, or functional measures. A biological age is only worth something if it predicts better than chronological age, and that criterion rules out a large share of published estimates.

Epigenetic clockMethylation clock#

Model that translates DNA methylation at thousands of sites into a numeric age. A 2022 study ran six clocks on duplicate samples: the same sample analyzed twice produced gaps of up to nine years. Methylation also varies with the tissue sampled and the analysis platform.

DunedinPACE#

Measure published in 2022 that estimates not an age but a speed of aging. It was modeled on the decline of nineteen indicators of organ integrity, tracked at four points over two decades in the New Zealand Dunedin cohort. It therefore answers a different question from clocks that report an age.

PhenoAgeDNAm PhenoAge#

Epigenetic clock published in 2018, trained on clinical and biological markers rather than chronological age. It predicts mortality and several age-related diseases better than chronological age in validation cohorts. Like all clocks, it remains sensitive to the tissue sampled and to measurement noise.

Telomere#

Protective end of chromosomes, which shortens with each cell division. Telomere length is associated with age and with some diseases, but it varies widely between people of the same age. Tests sold to the public have no demonstrated individual predictive value.

Cellular senescenceSenescent cell · SASP#

State in which a cell stops dividing without dying, and releases inflammatory molecules. It accumulates with age and contributes to low-grade inflammation. So-called senolytic drugs, which aim to clear these cells, are being studied in humans without an established clinical benefit to date.

SenolyticSenolytics · Dasatinib and quercetin#

Class of molecules that aim to eliminate senescent cells rather than block their activity. The candidates studied in humans are dasatinib combined with quercetin, and fisetin. Published trials cover markers and small samples, and no senolytic has demonstrated an effect on an age-related disease.

Hallmarks of agingAging hallmarks#

List of biological mechanisms associated with aging, published in 2013 and updated in 2023 with twelve entries: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, dysbiosis, inflammation, disrupted nutrient sensing and autophagy. These mechanisms overlap, and classifying them does not prove they are twelve independent causes.

Autophagy#

Process by which a cell digests and recycles its own damaged components. It is stimulated by fasting and exercise in animals, and its role in human aging is plausible but measured indirectly. No supplement sold as an autophagy activator has demonstrated an effect on human lifespan.

mTOR#

Signaling pathway that triggers protein synthesis when amino acids and energy are available. It is necessary for muscle building, which makes the idea of blocking it permanently absurd. The therapeutic interest studied concerns intermittent inhibition, not a shutdown.

AMPK#

Sensor of falling cellular energy, activated by exercise and a calorie deficit. It steers the cell toward energy production and repair rather than growth. It is a research target, not a parameter that is dosed in consultation.

Sirtuins#

Family of NAD+-dependent proteins involved in regulating gene expression and metabolism. Their link to longevity comes mostly from animal models. In humans, activators sold as sirtuin stimulants have no demonstration on lifespan.

NAD+Nicotinamide adenine dinucleotide#

Coenzyme essential to energy metabolism, whose level falls with age in some tissues. The precursors sold, NR and NMN, do raise circulating NAD+. No trial has shown that they extend life or prevent a disease in humans.

Mitochondrion#

Organelle that produces ATP, the energy a cell can use. Their number and quality decline with age and inactivity, and endurance exercise is the best documented lever to stimulate them. Supplements sold as mitochondrial support have no demonstrated effect on physical capacity.

Oxidative stress#

Imbalance between free radical production and antioxidant defenses. It is measurable, but antioxidant supplementation trials have not shown a benefit on mortality, and some have been associated with increased risk. Moderate exercise transiently raises oxidative stress and improves defenses.

Free radicalsReactive oxygen species · ROS#

Unstable molecules produced by metabolism, which can damage DNA, proteins and lipids. They are not only aggressors: they also serve as cellular signals. Hence the failure of strategies that seek to eliminate them entirely.

GlycationAdvanced glycation end products · AGEs#

Non-enzymatic binding of glucose to proteins, which produces rigid compounds called advanced glycation end products. They accumulate with age and hyperglycemia, and stiffen tissues. The best documented way to limit them remains control of average blood glucose.

Proteostasis#

Set of mechanisms that keep proteins correctly folded and remove those that are damaged. Their efficiency declines with age. It is a research mechanism, with no test available in consultation.

Stem cells#

Cells able to renew themselves and produce specialized cells. Their function declines with age, which limits tissue repair. Stem cell injections sold as anti-aging have no demonstrated benefit and carry infectious and tumor risks.

Life expectancy#

Average number of years remaining at a given age, in a given population and period. It is not a maximum: it depends on health conditions, and it is still rising in France. Confusing life expectancy with maximum lifespan is the most common error in discussions of the subject.

Healthy life expectancyHALE · Disability-free life expectancy#

Number of years lived without limitation in daily activities. In France, a man lives 79.4 years of which about 63.4 without limitation, a woman 85.3 years of which about 64.5. The gap between the sexes therefore concerns mainly the years with disability.

Compression of morbidity#

Hypothesis that the years gained would mostly be years in good health, pushing disease toward the end of life. French data confirm it only partially: disability-free life expectancy is rising, but more slowly than life expectancy.

Blue zoneBlue zones#

Name given to a few regions where a high proportion of centenarians is observed, such as Okinawa or Sardinia. Age verification has weakened several of these cases. The study of reliable data finds mostly classic factors: plant-based diet, physical activity and social ties.

Centenarian#

Person who has reached 100. Their number grows with life expectancy, and studies of supercentenarians suggest that part of their longevity is genetic. Individual cases prove nothing about a method: they describe, they do not recommend.

All-cause mortality#

Indicator that counts all deaths, whatever the cause. It is used in cohorts because it avoids arbitrarily choosing a disease. An association with all-cause mortality remains an association: it does not say through which mechanism the habit acts.

Walking speed#

Time taken to cover a short distance at usual pace. It is one of the two best validated measures of functional aging, and it is free. It predicts mortality and independence, and it can be re-measured under the same conditions without a laboratory.

Grip strengthHandgrip strength#

Maximum force of the hand grip, measured with a dynamometer. Second reference functional measure, used in sarcopenia screening and in monitoring a strength program. A drop of more than 10% between two comparable measurements warrants medical investigation.

Healthy agingHealthy ageing#

Trajectory in which physical and cognitive functions remain sufficient for independence. WHO defines it by intrinsic capacity, not by the absence of disease. It is the realistic target of coaching, more than extending lifespan.

Intrinsic capacity#

Combination of a person's physical and mental capacities, which WHO places at the center of healthy aging. It reads on mobility, cognition, nutrition, vision, hearing and mood. It often declines before disease is declared.

Cognitive decline#

Progressive decline in cognitive functions, memory and processing speed. It is partly age-related, but physical activity, control of blood pressure and blood glucose, and correction of sensory deficits change its trajectory. No supplement has demonstrated prevention.

Cognitive reserve#

Capacity of the brain to maintain performance despite lesions, thanks to a denser and more flexible network. It is built through education, stimulating activities and social ties. It is a plausible explanation for the gap between lesions seen at autopsy and symptoms.

Mild cognitive impairmentMCI#

Decline in cognitive functions documented by tests, which does not yet affect independence. Some cases remain stable, some progress to dementia. It is a reason for medical investigation, not a diagnosis to make in non-medical coaching.

OsteoporosisOsteopenia#

Loss of bone density and quality that increases fracture risk. Osteopenia designates the intermediate form, without fracture. Weight-bearing and resistance exercise act on the spine and hip, but the decision to treat belongs to the physician.

Epigenetics#

Set of chemical modifications that change gene expression without changing the DNA sequence. Methylation is the most studied. It is influenced by environment and age, which explains its use in clocks and its variability by tissue.

DNA methylation#

Addition of methyl groups at specific DNA sites, which modulates gene activity. It is the raw material of epigenetic clocks. The same sample analyzed twice can give different results, which requires knowing the measurement error before interpreting a gap.